A detailed history of Tranquility Partners, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tranquility Partners, LLC holds 5,260 shares of BMRN stock, worth $350,473. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,260
Previous 5,240 0.38%
Holding current value
$350,473
Previous $431,000 14.39%
% of portfolio
0.14%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$69.02 - $93.84 $1,380 - $1,876
20 Added 0.38%
5,260 $369,000
Q2 2024

Jul 25, 2024

BUY
$74.43 - $92.22 $390,013 - $483,232
5,240 New
5,240 $431,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Tranquility Partners, LLC Portfolio

Follow Tranquility Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tranquility Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tranquility Partners, LLC with notifications on news.